RIKEN CDB RIKEN CDB マウス(Spns2(loxP)), Spns2, loxP D (more than 6 months) Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> (1) The RECIPIENT shall obtain a prior agreement from the DEVELOPER Dr. Naoki Mochizuki (National Cerebral and Cardiovascular Center )(nmochizu@ri.ncvc.go.jp) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Acc.No. CDB0705K and Web Site (www2.clst.riken.jp/arg/mutant%20mice%20list.html) is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested (J Clin Invest. 2012 122(4):1416-26.). (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published. D（6か月以上） RBRC09357 Spns2(Acc.No.CDB0705K) Spns2(Acc.No.CDB0705K) true 条件を付加する。<br>(1) 分与希望者は事前に開発者 望月　直樹（国立循環器病センター研究所）(nmochizu@ri.ncvc.go.jp)に連絡をとり、分与に関して許可を得ること。（2）当該マウスを用いる論文発表に際してはAcc.No. CDB0705K、そのWEBサイト（www2.clst.riken.jp/arg/mutant%20mice%20list.html）とともに当該マウスを記載すること。（3）当該マウスを用いる論文発表に際しては、その由来として第一報論文 (J Clin Invest. 2012 122(4):1416-26.) を引用すること。（4）発表論文を寄託者 (mutant.bdr@riken.jp) に連絡すること。